Tokyo Tape
Sign in
← Delta-Fly Pharma

Quarterly report · Q2

4598.TEDINET S100PMWV
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 42
MetricValuePeriodScopeSource row
Operating income−¥612m2022-04-01 → 2022-09-30StandaloneOperating income
Operating income−¥554m2021-04-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥621m2022-04-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥964m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥556m2021-04-01 → 2021-09-30StandaloneOrdinary income
Profit before tax−¥621m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥556m2021-04-01 → 2021-09-30StandaloneIncome before income taxes
Net income−¥623m2022-04-01 → 2022-09-30StandaloneProfit loss
Net income−¥967m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income−¥557m2021-04-01 → 2021-09-30StandaloneProfit loss
Total assets¥734mat 2022-09-30StandaloneAssets
Total assets¥1.3bnat 2022-03-31StandaloneAssets
Total assets¥1.7bnat 2021-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥123mat 2022-09-30StandaloneLiabilities
Total liabilities¥91mat 2022-03-31StandaloneLiabilities
Net assets / equity¥611mat 2022-09-30StandaloneNet assets
Net assets / equity¥1.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2021-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥668mat 2022-09-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2022-03-31StandaloneCash and deposits
Cash & equivalents¥668mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥600m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥940m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥532m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥321,0002022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥37,0002022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥120m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥120m2021-04-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-114.882022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-57.932022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-178.582021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-102.972021-04-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-46.222021-07-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio83.1%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.1%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.3%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued5,419,600at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued5,419,600at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,419,600at 2021-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 321
ItemContextValueUnit
Purchase of treasury stock fin cfCurrentYTDDuration_NonConsolidatedMember-37000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration_NonConsolidatedMember119857000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember-37000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-709000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember73000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration_NonConsolidatedMember-412508000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember-600785000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember2088612000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1268492000JPY
Cash and cash equivalentsPrior1QuarterInstant_NonConsolidatedMember1676103000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember667706000JPY
Directors compensations sgaPrior1YTDDuration_NonConsolidatedMember44224000JPY
Directors compensations sgaCurrentYTDDuration_NonConsolidatedMember43600000JPY
Compensations sgaPrior1YTDDuration_NonConsolidatedMember56004000JPY
Compensations sgaCurrentYTDDuration_NonConsolidatedMember18066000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)四国財務局長
Filing date cover pageFilingDateInstant2022-11-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第13期第２四半期(自　2022年７月１日　至　2022年９月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Company name in english cover pageFilingDateInstantＤｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ，Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　江島　淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088-637-1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町３丁目11番５号日本橋ライフサイエンスビルディング２　６階
Telephone number nearest place of contact cover pageFilingDateInstant03-6231-1278
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE34318
Fund codeFilingDateInstant－
Security codeFilingDateInstant45980
Filer name in japaneseFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Filer name in englishFilingDateInstantDelta-Fly Pharma,Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-09-30
Previous fiscal year end dateFilingDateInstant2022-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass